Skip to main content
. 2023 Feb 12;39(2):207–216. doi: 10.1002/joa3.12832

TABLE 4.

Adverse outcomes.

Total (n = 89) Univentricular (n = 19) Biventricular (n = 70)
Worsening ventricular function 5 (6%) 0 (0%) 5 (7%)
Upgrade to multisite pacing 7 (8%) 0 (0%) 7 (12%)
Death 5 (6%) 2 (11%) 3 (4%)
Worsening NYHA class 3 (3%) 3 (16%) 0 (0%)
Heart transplant 2 (2%) 1 (5%) 1 (1%)
Total 22 (25%) 6 (32%) 16 (23%)

Note: The type and incidence of adverse outcomes in the two groups.